HLA-B57:01 Analyse Kit

Background on HLA-B*57:01

The HLA-B57:01 allele is part of the human leukocyte antigen (HLA) system, located within the major histocompatibility complex (MHC) on chromosome 6. HLA molecules are essential for antigen presentation and play a central role in immune system regulation. Specific allelic variants, such as HLA-B57:01, are associated with altered immune responses and drug hypersensitivity reactions.

HLA-B57:01 is strongly associated with hypersensitivity to abacavir, a nucleoside reverse transcriptase inhibitor used in the treatment of HIV infection. Individuals carrying this allele are at increased risk of developing severe immune-mediated adverse reactions upon exposure to the drug. As a result, detection of HLA-B57:01 is widely used in research focused on pharmacogenomics, immune response mechanisms, and personalized medicine approaches.

Reliable identification of this allele is essential for studies investigating genetic predisposition to drug hypersensitivity and variability in treatment response.

Kit Description

The HLA-B57:01™ Detection Kit is designed for the qualitative detection of the HLA-B57:01 allele using real-time PCR technology. The assay employs allele-specific oligonucleotides and fluorescent hydrolysis probes to enable precise amplification and detection within a single reaction.

The workflow is streamlined to reduce handling steps and minimize variability, supporting reproducible results across different laboratory settings. The kit is suitable for laboratories performing genetic and pharmacogenomic research.

Internal Control and Assay Reliability

An endogenous β-globin gene is included as an internal control to verify DNA quality and confirm proper assay performance. This control ensures that negative results are not caused by insufficient DNA input or PCR inhibition, supporting accurate and reliable interpretation.

The presence of this control contributes to consistent assay performance across different sample types and experimental conditions.

Reagents and Performance

All components of the HLA-B57:01™ Detection Kit are manufactured under strict quality standards to ensure reproducibility and reliability. The assay is optimized for high specificity, allowing accurate discrimination of the HLA-B57:01 allele from closely related variants.

The kit requires a low input of genomic DNA and is compatible with DNA extracted from peripheral blood or saliva. Validation has been performed using characterized samples and synthetic reference materials, confirming robust and reproducible performance.

Research Applications

Detection of the HLA-B*57:01 allele supports research into drug hypersensitivity mechanisms, particularly in relation to abacavir response. Identification of this genetic variant enables studies on pharmacogenomic risk factors, immune-mediated adverse reactions, and variability in treatment outcomes.

In addition, the assay can be used in broader research on immune system genetics, population studies, and genotype-phenotype correlations. Reliable genotyping supports the investigation of genetic factors influencing drug safety and efficacy.

Summary

The HLA-B57:01™ Detection Kit provides a reliable and reproducible solution for the detection of the HLA-B57:01 allele. Its real-time PCR-based workflow, internal control, and optimized assay design ensure accurate results with minimal procedural complexity.

Designed for integration into standard molecular biology workflows, the kit supports research into pharmacogenomics, immune response, and genetic susceptibility to drug hypersensitivity.